Trial Profile
A Phase IV Open-Label Pharmacokinetic Study of Minocycline for Injection Following a Single Infusion in Critically-Ill Adults (ACUMIN)
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 31 Aug 2020
Price :
$35
*
At a glance
- Drugs Minocycline (Primary)
- Indications Gram-negative infections
- Focus Pharmacokinetics
- Acronyms ACUMIN
- 15 Aug 2019 Status changed from recruiting to completed.
- 09 May 2019 Planned End Date changed from 31 Jan 2019 to 1 Aug 2019.
- 09 May 2019 Planned primary completion date changed from 31 Jan 2019 to 1 Aug 2019.